Published in Clin Rheumatol on September 02, 2007
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 5.36
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) (2003) 4.00
Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med (1990) 3.35
Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost (2000) 3.21
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med (1998) 1.86
Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med (1992) 1.82
Catastrophic antiphospholipid syndrome: where do we stand? Arthritis Rheum (2003) 1.79
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum (2004) 1.75
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood (2003) 1.37
Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med (1994) 1.30
Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol (2002) 1.20
Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore) (1992) 1.15
Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus (2003) 1.13
The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica (2006) 1.11
Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum (1992) 1.08
Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost (2002) 1.08
Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol (1994) 1.06
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum (2005) 1.05
Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation (1997) 0.99
Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective. Scand J Rheumatol (1996) 0.95
Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis (2004) 0.92
Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int (1991) 0.90
IL-4 and T cells are required for the generation of IgG1 isotype antibodies against cardiolipin. J Immunol (2002) 0.84
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.76
Outcomes and predictive factors of pediatric kidney transplants: an analysis of the Thai Transplant Registry. Pediatr Transplant (2013) 1.44
A 25-year experience of kidney transplantation in Thailand: report from the Thai Transplant Registry. Nephrology (Carlton) (2015) 1.42
Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant (2010) 0.97
Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis. Transplantation (2013) 0.92
Incidence and clinical correlation of anticentromere antibody in Thai patients. Clin Rheumatol (2005) 0.91
Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Semin Arthritis Rheum (2011) 0.90
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient. Southeast Asian J Trop Med Public Health (2013) 0.90
Renal phosphate loss in long-term kidney transplantation. Clin J Am Soc Nephrol (2011) 0.85
Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations. J Autoimmun (2005) 0.85
Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther (2006) 0.84
Overview of lupus nephritis management guidelines and perspective from Asia. Int J Rheum Dis (2013) 0.83
The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int (2012) 0.83
Overview of lupus nephritis management guidelines and perspective from Asia. Nephrology (Carlton) (2014) 0.83
Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus. Rheumatol Int (2010) 0.83
Mineral metabolism and outcomes in chronic kidney disease stage 2-4 patients. BMC Nephrol (2013) 0.81
Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease. J Pediatr Endocrinol Metab (2008) 0.80
Low hip bone mineral density predicts mortality in maintenance hemodialysis patients: a five-year follow-up study. Blood Purif (2014) 0.80
Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population? Rheumatol Int (2009) 0.78
Reappraisal of cervical spine subluxation in Thai patients with rheumatoid arthritis. Clin Rheumatol (2004) 0.78
Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study. J Med Assoc Thai (2006) 0.77
Raising rheumatoid factor cutoff helps distinguish rheumatoid arthritis. Asian Pac J Allergy Immunol (2005) 0.77
Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome. Clin Rheumatol (2007) 0.77
Possible protective effects of the Glu27 allele of beta2-adrenergic receptor polymorphism in Thai asthmatic patients. Asian Pac J Allergy Immunol (2010) 0.77
Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus. Rheumatol Int (2008) 0.76
Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients. Int J Rheum Dis (2012) 0.76
Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway. Clin Rheumatol (2006) 0.76
Asymptomatic avascular osteonecrosis of the hip in new patients diagnosed as systemic lupus erythematosus in Ramathibodi Hospital. J Med Assoc Thai (2007) 0.76
Vascular calcification in long-term kidney transplantation. Nephrology (Carlton) (2014) 0.75
Efficacy and safety of enoxaparin during hemodialysis: results from the HENOX study. J Med Assoc Thai (2011) 0.75
The 10th congress of the Asian Society of Transplantation--Part I. Preface. Transplant Proc (2008) 0.75
Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient. J Med Assoc Thai (2006) 0.75
The effect of religious practice on the prevalence of knee osteoarthritis. Clin Rheumatol (2009) 0.75